Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06400875 · ClinicalTrials.gov registry record

Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU

A clinical trial of Wound Heal and Ulcer Venous, sponsored by ConvaTec.

Active
Registry status
37
Enrollment target
1
Study location

NCT06400875 is a study of Wound Heal and Ulcer Venous that is active but no longer recruiting, run by ConvaTec. The registered enrollment target is 37 participants, below the 118-participant average among 23 other Wound Heal trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06400875, a study of Wound Heal and Ulcer Venous, is active but no longer recruiting, sponsored by ConvaTec.

ACTIVE NOT RECRUITING
Registry status
37 participants
Enrollment target
1
Study location

Study Summary

The study is a multi-center, prospective, clinical trial designed to evaluate the use of InnovaMatrix AC sterilized porcine placental ECM to treat chronic VLUs . The trial will include 30 completed subjects at multiple, experienced clinical centers in the United States.

Conditions Studied

Interventions

  • DEVICE InnovaMatrix® AC Sterilized, Porcine Placental Extracellular Matrix (ECM)

Study Locations (1)

Massachusetts

  • The Serena Group - Cambridge

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2023-07-10
Est. Completion 2025-12-31

Sponsor

ConvaTec

17 total trials

What the Registry Record Tells You About NCT06400875

The ClinicalTrials.gov registry entry for NCT06400875 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 118-participant average among 23 other Wound Heal trials with a reported enrollment target (69% lower). The listed sponsor is ConvaTec, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Wound Heal appearing as the primary indexed condition, and to 1 intervention - of which InnovaMatrix® AC Sterilized, Porcine Placental Extracellular Matrix (ECM) is the first listed.

NCT06400875 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06400875 about?

NCT06400875 is a clinical study titled "Observational Study to Investigate the Use of Sterilized Porcine Placental Tissue in the Treatment of Chronic VLU". The study is a multi-center, prospective, clinical trial designed to evaluate the use of InnovaMatrix AC sterilized porcine placental ECM to treat chronic VLUs . The trial will include 30 completed subjects at multiple, experienced clinical centers in the United States.

What is the current status of trial NCT06400875?

This trial is currently active not recruiting. The enrollment target is 37 participants. The study started on 2023-07-10. Estimated completion is 2025-12-31.

What conditions does trial NCT06400875 study?

This clinical trial studies the following conditions: Wound Heal, Ulcer Venous.

What interventions are being tested in trial NCT06400875?

The interventions under investigation include: InnovaMatrix® AC Sterilized, Porcine Placental Extracellular Matrix (ECM) (DEVICE).

Who is sponsoring clinical trial NCT06400875?

This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06400875 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wound Heal

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.